For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

Graphic designer Jakob Trollbäck remembers a 2014 meeting with film director Richard Curtis and the United Nations Sustainable Development ... individual icons and logo of the SDGs.

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...

The FDA Fast Track and Accelerated Approval pathways have major implications for the wider healthcare landscape beyond drug ...

Analyst Gil Blum from Needham maintained a Buy rating on Recursion Pharmaceuticals (RXRX – Research Report) and keeping the price target ...

Joint efforts promise innovative drug solutions and enhanced offerings while enabling comprehensive development of active ...

The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...

Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...

STOCKHOLM, SWEDEN, November 5 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has succesfully completed a pre-IND meeting with the ...

de-risking early-stage development, or leveraging the potential of AI in its work. DSI provides regulatory, technical, and ...